RE:RE:Bring it on !Vista5 wrote: You are so correct I will add anyone of those events will have a serious positive impact on the price of this stock. Let's also add to that they will be fully funded when the warrants are exercised. Another 20+mm Only the beginning. IMHO I see over $5.00
You may be light on that estimate!
That's only a billion or so USD valuation.
Diagnostics are the future of medicine - especially post-Covid. There is not, nor will there be enough $ in the healthcare system for old style healh care to work (e.g Dr visits, expensive tests, time consuming tests, inefficient labs & clinics, etc.
A decade ago Theranos tried to tap into this future. (black box that could analyze a drop of blood and diagnose anything). Only problem, they did not have the technology to back it up. It became a market darling, based on smoke and mirrors, not science. They acheived $ 9B USD valuation before crashing.
Fast forward to today. SQI has the proven science behind them (in co-operation with the UHN) Adding diagnositcs all the time, setting up the sophisticated diagnostic labs for quick and accurate turn-around. The mixed blessing of Covid is that it will greatly accelerate the market acceptance of remote diagnostics. And Covid diagnostics (Antibody) demand the ultimate in precision - which SQI has. They could surpass Theranos in market cap one day...but this time it will be real. Then add the world wide transplant component. I'll let you do the math on what the share price would be (in Cdn and USD) if it can capture the attention of the US market. Hint: It's almost scary !
MM